まとめ
強化された心房節伝導 (EAVC) は,生理学的減速の減少を伴う. 自律的封鎖は,EAVCとEAVC以外の患者に異なった影響を及ぼし,潜在的構造的要因が伝導の変動に寄与することを示唆しています.
科学分野:
- 心臓病学と電気生理学
- 人間の生理学 人間生理学
- 自律神経系の機能 自律神経系の機能
背景:
- 強化された心房回路結節伝導 (Enhanced atrioventricular nodal conduction,EAVC) は,心房回路結節電気生理学のスペクトルであり,伝導の遅延が軽減されています.
- EAVCの電気生理学的基礎を理解することは,関連する心臓病の診断と管理に不可欠です.
研究 の 目的:
- EAVCの電気生理学的特徴における自律神経系制御の役割を調査する.
- EAVCの患者および無患者の心房節伝導および屈折性に対する薬理学的な自律的阻害の効果を比較する.
主な方法:
- 電気生理学的研究は,EAVCを患った患者10名,EAVCを患っていない患者12名 (非EAVC) で実施されました.
- プロプラノロールとアトロピンを用いて,薬理学的な自律的ブロックが誘発されました.
- 閉塞前と閉塞後の心房節伝導,屈折性,およびサイクル長さを測定した.
主要な成果:
- 自律的封鎖は,両群のシナウスサイクルの長さと心房耐火期にも同様の影響を及ぼした.
- EAVC患者では,1:1の心房内伝導率を持つ最低心房ペースサイクルの長さは,閉塞後の (268〜307 ms) 期間を大幅に延長しました.
- 非EAVC患者では,最低サイクルの長さ (392〜382ミリ秒) に有意な変化は見られず,EAVC患者では,封鎖後の機能性耐火期が短かった.
結論:
- 自動制御は,EAVCで観察された電気生理学的違いに貢献しますが,完全に説明することはありません.
- 基礎となる構造的または機能的要因は,ヒトにおける心房節の電気生理学的特徴を決定する上で重要な役割を果たす可能性が高い.
関連する概念動画
01:28Drugs Acting on Autonomic Ganglia: Blockers
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...